肝癌合并肝硬化病人肝切除术后液体治疗方案的探讨

目的探讨肝癌合并肝硬化病人肝切除术后的液体治疗的合理方案，降低围手术期容量风险。方法回顾性分析60例肝癌合并肝硬化病人肝切除术后液体治疗方案：根据治疗方法不同分为三组：A组（n=20）给予等渗晶体液；B组（n=20）等渗晶体液与羟乙基淀粉（130／0．4）以2：1比例输注；C组（n=20）予7．5％氯化钠溶液、等渗晶体液与羟乙基淀粉（130／0．4）输注。三组均间断给予利尿剂。C组术后1、4、7天肝功能指标，术后肠道排气时间，腹水消退时间均显著优于A、B组，而且达到治疗目标所需的输液量最少。结论羟乙基淀粉（130／0．4）溶液及小剂量高渗盐水的联合使用效果显著，是肝癌术后患者较合理的液体治疗方案。

Study of postoperative fluid therapy for patients with hepatocarcinoma associated with liver cirrhosis

Objective To investigate the reasonable project of postoperative fluid therapy for receiving hepatectomy patients with hepatocarcinoma asociated with liver cirrhosis. Methods Data of 60 patients with hepatocarcinoma associated with liver cirrhosis were analyzed retrospectively. The patients were randomly divided into three groups according to the different types of fluid therapy. Patients Group A(n=20) were treated with isotonic solution. Group B (n=20)were given hydroxyethyl starch(130 / 0.4) and isotonic ...